GIỚI THIỆU VỀ TẬP NÀY
In this episode, Arno Sosna, president of the CRM Suite at Veeva, joins Maria Whitman to explore how AI is transforming CRM in life sciences into a dynamic engine for insight and action. They unpack the emergence of Commercial Evidence™—real-time insights into treatment barriers—and how conversational, agentic AI unlocks a new, faster way to understand and serve customers. The conversation offers a look at how this shift fundamentally reshapes decision-making, workflows and ultimately patient access to care.
Highlights:
- Why traditional CRM models miss the full picture behind treatment barriers—and how AI generates actionable Commercial Evidence at scale
- How conversational AI in CRM enables a continuous, omnichannel dialogue between commercial teams and HCPs
- What it takes to move from insight to impact using AI to drive precision engagement, not just collect more data
- Why removing friction between patients and treatment isn’t just a goal, but a “moral obligation” for the industry
Tiếng Anh
Hoa Kỳ
BẢN CHÉP ÂM THANH 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
TÌM KIẾM CÁC TẬP TRƯỚC
Tìm kiếm các tập trước của Transforming Biopharma .
CÁC TẬP KHÁC TRONG PODCAST NÀY
If we want to make change in healthcare, we can’t take a one-dimensional approach. We need a multifaceted plan. Having just celebrated its 100th anniversary, the American Heart Association (AHA) is pursuing that vision. Maria Whitman talks with Juliana Crawford, EVP of emerging strategies at the AH…
Clinical trial sites are important players in biopharma’s success. In this episode, we hear from site experts Lauren Wall of the University of Chicago and Caroline Smith of Charter Research on how pharma can forge successful partnerships. While good communication, transparency and collaboration are…
What’s the role of culture in an organization and how can it play a pivotal role in shaping performance or even helping businesses transform? Maria Whitman sits down with Paul Ingram, professor of business at Columbia University, to explore the critical role of culture and organizational dynamics i…
Joe DePinto, McKesson’s head of cell and gene advanced therapies, supports patients, providers and payers throughout the treatment journey. He’s particularly passionate about helping patients get access to groundbreaking therapeutic interventions. Maria Whitman gets his perspective on the current s…
Maria Whitman interviews Mike Tushman, professor at Harvard Business School, about the importance of organizational architecture during times of transformation. He describes how companies that successfully transform create an organizational architecture that allows both “exploitation” of existing s…
Tuyên bố miễn trừ trách nhiệm: Podcast và tác phẩm nghệ thuật được nhúng trên trang này là của ZS, là tài sản của chủ sở hữu và không được liên kết hoặc xác nhận bởi Listen Notes, Inc.
CHỈNH SỬA
Cảm ơn bạn đã giúp cơ sở dữ liệu podcast luôn cập nhật.
